# Diabetes-associated modifications in gut microbiota and tryptophan metabolism: implications for macrophage polarization and wound repair in mice

**Authors:** Yiming Ni, Jiawei Feng, Wei Zhang, Min Tang, Shiyu Wang, Rong Shi, Mingmei Zhou, Cheng Zhao

PMC · DOI: 10.1186/s12866-025-04629-6 · 2026-01-07

## TL;DR

This study shows that diabetes disrupts gut bacteria and tryptophan metabolism, leading to poor wound healing in mice due to imbalanced immune responses.

## Contribution

The study systematically links gut microbiota dysbiosis and tryptophan metabolism to impaired wound healing and macrophage polarization in a T2DM mouse model.

## Key findings

- T2DM mice showed delayed wound healing, reduced collagen, and persistent inflammation.
- Gut microbiota in T2DM mice had lower diversity and fewer Lactobacillus species linked to better healing.
- Reduced tryptophan-indole metabolites in T2DM mice correlated with impaired macrophage function and pro-inflammatory states.

## Abstract

Diabetic wound (DW) is a severe complication of diabetes with poor healing, linked to gut microbiota dysbiosis, metabolic imbalance, and macrophage polarization disorder. This study aimed to systematically explore the role of the gut-skin axis in DW.

A type 2 diabetes mellitus (T2DM) mouse model was established via high-fat diet feeding and streptozotocin injection. Wound healing was evaluated by histological and immunofluorescence analyses. Gut microbiota composition (16 S rRNA sequencing), serum non-targeted metabolomics (GC-MS), and targeted tryptophan metabolite detection (UPLC-MS/MS) in cecal contents and wound tissues were also performed. Macrophage polarization and cytokine levels were assessed by immunofluorescence and ELISA, respectively.

T2DM mouse model showed delayed wound healing, reduced collagen deposition, impaired neovascularization, and persistent inflammation. 16 S rRNA sequencing revealed decreased gut α-diversity and significantly lower abundances of Lactobacillus johnsonii, Lactobacillus reuteri, and Lactobacillus sp. KC38 in T2DM mice. These Lactobacillus species were positively correlated with wound healing rate. Metabolomic analyses demonstrated suppressed tryptophan-indole metabolism in T2DM mice: cecal and wound levels of indole-3-propionic acid, indole-lactic acid, and other indole metabolites were reduced, accompanied by downregulated aromatic amino acid transaminase and phenyllactate dehydrogenase expression. T2DM mice also exhibited M1 macrophage persistence (elevated CD68 in wound and elevated IL-6, TNF-α, iNOS in serum) and M2 macrophage deficiency (reduced CD206 in wound and decreased IL-10, TGF-β, Arg-1 in serum), with impaired myofibroblast activity (α-SMA) and angiogenesis (CD31). Wound tryptophan-indole metabolites were positively correlated with healing-promoting indices and negatively correlated with pro-inflammatory markers.

The reduction in gut Lactobacillus abundance induced by T2DM is associated with disrupted tryptophan-indole metabolism, which may impair macrophage polarization and wound healing. This study provides a systematic basis for microbiota-targeted therapies for diabetic wounds.

The online version contains supplementary material available at 10.1186/s12866-025-04629-6.

## Linked entities

- **Proteins:** CD68 (CD68 molecule), MRC1 (mannose receptor C-type 1), PECAM1 (platelet and endothelial cell adhesion molecule 1), ACTA1 (actin alpha 1, skeletal muscle), NOS2 (nitric oxide synthase 2), ARG1 (arginase 1)
- **Chemicals:** tryptophan (PubChem CID 1148), indole-3-propionic acid (PubChem CID 3744), indole-lactic acid (PubChem CID 92904)
- **Diseases:** type 2 diabetes mellitus (MONDO:0005148)
- **Species:** Lactobacillus johnsonii (taxon 33959), Lactobacillus sp. KC38 (taxon 120548)

## Full-text entities

- **Genes:** Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}
- **Diseases:** DW (MESH:D003920), T2DM (MESH:D003924), inflammation (MESH:D007249)
- **Chemicals:** indole-3-propionic acid (-), indole (MESH:C030374), tryptophan (MESH:D014364), indole-lactic acid (MESH:C024139), streptozotocin (MESH:D013311)
- **Species:** Lactobacillus sp. (species) [taxon 1591], Limosilactobacillus reuteri (species) [taxon 1598], Lactobacillus johnsonii (species) [taxon 33959], Mus musculus (house mouse, species) [taxon 10090]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12908399/full.md

---
Source: https://tomesphere.com/paper/PMC12908399